Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
5
×
san francisco blog main
san francisco top stories
biotech
national
alnylam pharmaceuticals
amgen
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
immunotherapy
indiana blog main
indiana top stories
investing
medicare
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
What
market
5
×
drug
fda
new
patients
advantages
arrival
bar
bio
biotech
bringing
brings
cancer
cholesterol
clears
close
closer
companies
data
days
eisai
expect
filing
flags
forward
gamble
gene
hasn’t
heated
hemophilia
higher
inched
incidence
industry
ipo
ipos
life
lorcaserin
loss
lowering
Language
unset
Current search:
market
×
" new york top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race